291 results
Page 6 of 15
8-K
h05drsg 1b5hq
16 Jun 20
Departure of Directors or Certain Officers
5:27pm
S-8
EX-99.1
qk6pb2uey
16 Jun 20
Registration of securities for employees
4:52pm
8-K
EX-10.1
rbazygorvvtf3
29 May 20
AcelRx Pharmaceuticals Announces Revised Merger Agreement with Tetraphase
5:12pm
8-K
EX-2.1
de7g5d61681
29 May 20
AcelRx Pharmaceuticals Announces Revised Merger Agreement with Tetraphase
5:12pm
425
EX-2.1
o0j4be5q
29 May 20
Business combination disclosure
5:10pm
425
EX-10.1
od5s486h2wply
29 May 20
Business combination disclosure
5:10pm
425
EX-2.1
sl7r4 rsqbd3
29 May 20
Business combination disclosure
8:54am
425
EX-10.1
pgz764
29 May 20
Business combination disclosure
8:54am
8-K
EX-2.1
sz98uak8
27 May 20
AcelRx Pharmaceuticals Announces Revised Merger Agreement with Tetraphase
5:03pm
8-K
EX-10.1
1hc85c6njmak 64
27 May 20
AcelRx Pharmaceuticals Announces Revised Merger Agreement with Tetraphase
5:03pm
425
EX-10.1
0e7ulz0d
27 May 20
Business combination disclosure
5:01pm
425
EX-2.1
4ldpf7v1mgl
27 May 20
Business combination disclosure
5:01pm
425
EX-2.1
ivk90n24vrr8d6p v4n
27 May 20
Business combination disclosure
9:29am
425
EX-10.1
q3ju3kq qtr7ie9bv5
27 May 20
Business combination disclosure
9:29am
8-K
EX-99.2
yc43 co61
30 Apr 20
AcelRx Announces DSUVIA® Milestone C Approval
8:24am